PMC:7396557 / 75252-75451 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T93150","span":{"begin":19,"end":24},"obj":"Chemical"},{"id":"T198","span":{"begin":37,"end":39},"obj":"Chemical"}],"attributes":[{"id":"A25748","pred":"chebi_id","subj":"T93150","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A81370","pred":"chebi_id","subj":"T198","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"In the XBJI 100 ml group, the APACHE II score after treatment was significantly lower than those in the routine treatment and XBJI 50 ml groups (12.3 ± 1.5 vs. 16.5 ± 1.6, 15.9 ± 1.4, both p \u003c 0.05)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T560","span":{"begin":0,"end":199},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the XBJI 100 ml group, the APACHE II score after treatment was significantly lower than those in the routine treatment and XBJI 50 ml groups (12.3 ± 1.5 vs. 16.5 ± 1.6, 15.9 ± 1.4, both p \u003c 0.05)."}